Latrepirdine: all 27 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug UsersCompletedNCT00975481Phase 1Results posted
- An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's DiseaseTerminatedNCT00939783Phase 3Results posted
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's DiseaseTerminatedNCT00912288Phase 3Results posted
- A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's DiseaseCompletedNCT00838110Phase 3Results posted
- DMB-I in the Treatment of Alzheimer Type DementiaCompletedNCT06292351Phase 2
- An Extension of the CONCERT Protocol (DIM18)TerminatedNCT01152216Phase 3
- An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington DiseaseTerminatedNCT01085266Phase 3
- A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's DiseaseWithdrawnNCT01066481Phase 2
- A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The SkinCompletedNCT00990613Phase 1
- A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)CompletedNCT00988624Phase 1
- A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's DiseaseTerminatedNCT00954590Phase 3
- A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 MetabolizersCompletedNCT00931073Phase 1
- A Safety and Efficacy Study of Dimebon in Patients With Huntington DiseaseCompletedNCT00920946Phase 3
- A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy AdultsCompletedNCT00907322Phase 1
- Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic FunctionCompletedNCT00831532Phase 1
- Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy SubjectsCompletedNCT00831506Phase 1
- Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus DonepezilCompletedNCT00829816Phase 1
- Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on DonepezilCompletedNCT00829374Phase 3
- A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy SubjectsCompletedNCT00827034Phase 1
- A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy SubjectsCompletedNCT00825084Phase 1
- A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal FunctionCompletedNCT00824590Phase 1
- A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of DextromethorphanCompletedNCT00788047Phase 1
- Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's DiseaseTerminatedNCT00704782Phase 2
- A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's DiseaseCompletedNCT00675623Phase 3
- A Study of the Novel Drug Dimebon in Patients With Huntington's DiseaseCompletedNCT00497159Phase 2
- Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's DiseaseCompletedNCT00387270Phase 1/2
- Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT00377715Phase 2